Setting in motion the immune mechanisms underlying genetically determined resistance and susceptibility to infection with Leishmania major

Parasite Immunology

Volumn 20, Issue 5, 1998, Pages 223-230

  Launois, Pascal ^a   Conceiçao Silva, Fatima ^a   Himmerlich, Hayo ^a   Parra Lopez, Carlos ^a   Tacchini Cottier, Fabienne ^a   Louis, Jacques A ^a,b  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

APO 1 (cd 95) pathway; IL 4; L. major; Lack; Th1 Th2 cells

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; HOST PARASITE INTERACTION; HOST RESISTANCE; HOST SUSCEPTIBILITY; INFECTION RESISTANCE; LEISHMANIA MAJOR; LEISHMANIASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ANIMALIA; LEISHMANIA MAJOR; MURINAE;

EID: 0031830650     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3024.1998.00153.x     Document Type: Conference Paper

References (77)

1. Afonso L.C.C., Sharton T.M., Vieira L.Q., Wysocka M., Trinchieri G. & Scott P. (1994) The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263, 235-237
2. Assreuy J., Cunha F.Q., Epperlein M. et al. (1994) Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major. European Journal of Immunology 24, 672-676
3. Beebe A., Mauze S., Schork N.J. & Coffman R.L. (1997) Serial backcross mapping of multiple loci associated with resistance to Leishmania major in mice. Immunity 6, 551-557
4. Benin R., Maüel J. & Sordat B. (1979) Leishmania tropica: pathogenicity and in vitro macrophage function of inbred mice. Experimental Parasitology 48, 81-91
5. Blackwell J.M., Hale C., Roberts M.B., Ulczack O.M., Liew F.Y. & Howard J.G. (1985) An H-11-linked gene has a parallel effect on Leishmania major and L. donovani infections in mice. Immunogenetics 21, 385-395
6. + T cells are nor essential for T helper cell 2 immune responses. Journal of Experimental Medicine 184, 1295-1304
7. Conceiçao-Silva F., Hahne M., Schröter M., Louis J. & Tschopp J. (1998) The resolution of lesions induced by Leishmania major in mice requires a functional Fas(APO-1, CD95) pathway of cytotoxicity. European Journal of Immunology (in press)
8. Corry D.B., Reiner S.L., Linsley P.S. & Locksley R.M. (1994) Differential effects of blockade of CD28-B7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis. Journal of Immunology 153, 4142-4148
9. D'Andrea A., Rengaraju M., Valiante N.M. et al. (1992) Production of natural killer cell stimulatory factor (interleukin-12) by peripheral blood mononuclear cells. Journal of Experimental Medicine 176, 1387-1398
10. Evans T.G., Thai L., Granger D.L., & Hibbs Jr J.B. (1993) Effect of in vivo inhibition of nitric oxide production in murine leishmaniasis. Journal of Immunology 151, 907-915.
11. Gorham J.D., Güler M.L., Steen R.G. et al. (1996) Genetic mapping of a murine locus controlling development of T helper 1/T helper 2 type responses. Proceedings of the National Academy of Sciences, USA 93, 12467-12472
12. Green S.J., Meltzer M.S., Hibbs J.B. & Nacy C.A. (1990) Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine dependent killing mechanism. Journal of Immunology 144, 278-286
13. Güler M.L., Gorham J.D., Hsieh C.S. et al. (1996) Genetic susceptibility to Leishmania: IL-12 responsiveness in Th1 cell development. Science 271, 984-987
14. Güler M.L. Jacobson N.G., Gubler U & Murphy K.M. (1997) T cell genetic background determines maintenance of IL-12 signalling. Effects on BALB/c and B10.D2 T helper cell type 1 phenotype development. Journal of Immunology 159, 1767-1774
15. Heinzel F.P., Sadick M.D., Holaday B.J., Coffman R.L. & Locksley R.M (1989) Reciprocal expression of interferon γ or interleukin 4 during the resolution or progression of murine leishmaniasis. Journal of Experimental Medicine 169, 59-72
16. Heinzel F.P., Schoenhaut D.S., Rerko R.M., Rosser L.E. & Gately M.K. (1993a) Recombinant interleukin 12 cures mice infected with Leishmania major. Journal of Experimental Medicine 177, 1505-1509
17. Heinzel F.P., Rerko R.M., Hatam F. & Locksley R.M. (1993b) IL-2 is necessary for the progression of leishmaniasis in susceptible murine hosts. Journal of Immunology 150, 3924-3931
18. Heinzel F.P., Rerko R.M., Ahmed F. & Pearlman E. (1995) Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating Leishmaniasis in normally resistant mice. Journal of Immunology 155, 730-739
19. Holaday B.J., Sadick M.D., Wang Z.-E. et al. (1991) Reconstitution of Leishmania immunity in severe combined immunodeficient mice using Th1- and Th2-like cell lines. Journal of Immunology 147, 1653-1658
20. Howard J.G., Hale C., & Chan-Liew W.L. (1980) Immunological regulation of experimental cutaneous leishmaniasis. 1. Immunogenetic aspects of susceptibility to Leishmania tropica in mice. Parasite Immunology 2, 303-314
21. Hsieh C.-S., Heimberger A.B., Gold J.S., O'Garra A. & Murphy K.M. (1992) Differential regulation of T helper phenotype development by interleukins 4 and 10 in an αβ T-cell-receptor transgenic system. Proceedings of the National Academy of Sciences, USA 89, 6065-6069
22. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260, 547-549
23. Hsieh C.S., Macatonia S.E., O'Garra A. & Murphy K.M. (1995) T cell genetic background determines default T helper phenotype development in vitro. Journal of Experimental Medicine 181, 713-721
24. + cytotoxic T cells. Proceedings of the National Academy of Sciences, USA 91, 4189-4285
25. Julia V., Rassoulzadegan M. & Glaichenhaus N. (1996) Resistance to Leishmania major induced by tolerance to a single antigen. Science 274, 421-423
26. Kopf M., Brombacher F., Kölher G. et al. (1996) IL-4 deficient Balb/c mice resist infection with Leishmania major. Journal of Experimental Medicine 184, 1127
27. + T cells which are NK1.1-. European Journal of Immunology 25, 3298
28. Launois P., Swihart K., Milon G. & Louis J.A. (1997a) Early production of IL-4 in susceptible mice infected with Leishmania major rapidly induces IL-12 unresponsiveness. Journal of Immunology 158, 3317-3324
29. + T cells in BALB/c mice infected with Leishmania major instructs Th2 cell development and susceptibility to infection. Immunity 6, 541-549
30. Launois P., Tacchini-Cottier F., Parra-Lopez C. & Louis J.A. (1998) Cytokines in parasitic diseases: the example of cutaneous leishmaniasis. International Review. of Immunology (in press)
31. Liew F.Y., Hale C. & Howard J.G. (1985) Prophylactic immunization against experimental leishmaniasis. IV. Subcutaneous immunization prevents the induction of protective immunity against fatal Leishmania major infection. Journal of Immunology 135, 2095-2101
32. Liew F.Y., Millott S., Li Y., Chan W.L. & Ziltener H. (1989) Macrophage activation by interferon-γ from host-protective T cells is inhibited by interleukin (IL)3 and IL4 produced by disease-promoting T cells in leishmaniasis. European Journal of Immunology 19, 1227-1232
33. Liew F.Y., Millott S., Parkinson C., Palmer R.M. & Moncada S. (1990) Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. Journal of Immunology 144, 4794-4797
34. Locksley R.M., Heinzel F.P., Sadick M.D., Holaday B.J. & Gardner K.D. (1987) Murine cutaneous leishmaniasis: Susceptibility correlates with differential expansion of helper T cell subset. Am. Inst. Pasteur/Immunol. 138, 744-749
35. + T cells from αβ TCR transgenic mice: IL-12 substitution for macrophages to stimulate IFN-γ production is IFN-γ dependent. International Immunology 5, 1119-1128
36. + T cells. Journal of Immunology 154, 5071-5079
37. Magram J., Connaughton S.E., Warrier R.R. et al. (1996) IL-12-deficient mice are defective in IFN-γ production and type 1 cytokine responses. Immunity 4, 471-481
38. Maillard I., Erny K., Acha-Orbea H. & Diggelmann H. (1996) A Vβ4-specific superantigen encoded by a new exogenous mouse mammary tumor virus. European Journal of Immunology 26, 1000-1006
39. Mattner F., Magram J., Ferrante J. et al. (1996) Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. European Journal of Immunology 26, 1553-1559
40. Mauël J., Betz Corradin S. & Buchmüller Rouiller Y. (1991) Nitrogen and oxygen metabolites and the killing of Leishmania by activated murine macrophages. Research in Immunology 142, 577-580
41. + T cells in susceptible BALB/c as compared with resistant CBA mice. Journal of Immunology 136, 1467-1471
42. Mitchell G.F., Curtis J.M., Scollay R.G. & Handman E. (1981) Resistance and abrogation of resistance to cutaneous leishmaniasis in reconstituted BALB/c mice. Australian Journal of Experimental Biology and Medical Science 59, 539-544
43. Mitchell G.F. (1983) Murine cutaneous leishmaniasis: resistance in reconstituted nude mice and several F1 hybrids infected with Leishmania tropica major. Journal of Immunogenetics 10, 395-412
44. Mock B., Blackwell J., Hilger J., Potter M. & Nacy C. (1993) Genetic control of Leishmania major infection in congenic, recombinant inbred and F2 populations of mice. European Journal of Immunogenetics 20, 335-348
45. + cells secreting interleukin 4. International Immunology 5, 761-767
46. Morris L., Troutt A.B., McLeod K.S., Kelso A., Handman E. & Aebischer T. (1993b) Interleukin 4 but not gamma interferon production correlates with the severity of murine cutaneous leishmaniasis. Infection and Immunity 61, 3459-3465
47. Mosmann T.R. & Coffman R.L. (1989) Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annual Review of Immunology 7, 145-173
48. Mougneau E., Altare F., Wakil A.E. et al. (1995) Expression cloning of a protective Leishmania antigen. Science 268, 563-566
49. + T cell clones recognizing antigen(s) associated with live parasites. European Journal of Immunology 19, 865-871
50. Noben-Trauth N., Kropf P. & Müller I. (1996) Susceptibility to Leishmania major infection in IL-4 deficient mice. Science 271, 912-913
51. Ramsdell F., Seaman M., Miller R., Picha K., Kennedy M. & Lynch D. (1994) Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death. International Immunology 6, 1545-1553
52. Reiner S.L., Wang Z.-E., Hatam F., Scott P. & Locksley R.M. (1993) TH1 and TH2 cell antigen receptors in experimental leishmaniasis. Science 259, 1457-1460
53. Roberts M., Mock B.A. & Blackwell J.M. (1993) Mapping of genes controlling Leishmania major infection in CXS recombinant inbred mice. European Journal of Immunogenetics 20, 349-362
54. + T cells producing IL-2 and IL-4. Journal of Immunology 148, 1031-1036
55. Sadick M.D., Heinzel F.P., Holaday B.J. et al. (1990) Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent interferon-γ independent mechanism. Journal of Experimental Medicine 171, 115-127
56. Scharton-Kersten T., Afonso L.C.C., Wysocka M., Trinchieri G. & Scott P. (1995) IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. Journal of Immunology 154, 5320-5330
57. Scott P.A. (1991) IFN-γ modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. Journal of Immunology 147, 3149-3155
58. + T cells from T cell receptor transgenic mice. Journal of Experimental Medicine 176, 1091-1098
59. + T cells to enhance priming for interferon-γ production and diminishes interleukin 4 inhibition of such priming. Proceedings of the National Academy of Sciences, USA 90, 10188-10192
60. Solbach W., Forberg K., Kammerer E., Bogdan C. & Rollinghoff M. (1986) Suppressive effect of cyclosporin A on the development of Leishmania tropica induced lesions in genetically susceptible BALB/c mice. Journal of Immunology 137, 702-707
61. + T cell mediated cytotoxicity. Journal of Immunology 152, 1127-1133
62. Stenger S., Donhauser N., Thürin H., Röllinghoff M. & Bogdan C. (1996) Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. Journal of Experimental Medicine 183, 1501-1514
63. + T cell response. Journal of Experimental Medicine 181, 961-971
64. Sypek J.P., Chung C.L., Mayor S.E.H. et al. (1993) Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. Journal of Experimental Medicine 177, 1793-1802
65. Szabo S.J., Jacobson N.G., Digne A.S., Gübler U. & Murphy K.M. (1995) Developmental commitment to the Th2 lineage by extinction of IL-12 signalling. Immunity 2, 665-675
66. Szabo S.J., Dighe A.S., Gübler U., & Murphy K.M. (1997) Regulation of the interleukin (IL)-12R β2 subunit expression in developing T helper (Th)1 and Th2 cells. Journal of Experimental Medicine 185, 817-824
67. Titus R.G., Lima G.C., Engers H.D. & Louis J.A. (1984) Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite specific helper T cell population capable of mediating Leishmania major specific delayed-type hypersensitivity. Journal of Immunology 133, 1594-1600
68. Titus R.G., Ceredig R., Cerottini J.C. & Louis J.A. (1985) Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice. Journal of Immunology 135, 2108-2114
69. - T cell population. Journal of Immunology 157, 4421-4427
70. Wang Z.E., Zheng S., Corry D.B. et al (1994a) Interferon gamma-independent effects of interleukin 12 administered during acute or established infection due to Leishmania major. Proceedings of the National Academy of Sciences, USA 91, 12932-12936
71. + effector cells default to the Th2 pathway in interferon γ-deficient mice infected with Leishmania major. Journal of Experimental Medicine 179, 1367-1371
72. Wei X.-Q., Charles I.G., Smith A. et al. (1995) Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375, 408-411
73. Wenner C.A., Güler M.L., Macatonia S.E. et al (1996) Roles of IFN-γ and IFN-α in IL-12-induced T helper cell-1 development. Journal of Immunology 156, 1442-1447
74. + T cells in a Th2 response and in immunoglobulin E production. Science 270, 1845-1847
75. pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. Journal of Experimental Medicine 179, 1285-1295
76. Zhang X., Brunner T., Carter L. et al. (1997) Unequal death in T helper cell (Th)1 and Th2 effectors: Th1 but not Th2 effectors undergo rapid Fas/FasL-mediated apoptosis. Journal of Experimental Medicine 185, 1837-1849
77. Zurawski G. & de Vries J.E. (1994) Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunology Today 15, 19-26